Brief: Burning Rock Biotech Announces Expected Delisting Of American Depositary Shares
Aug 19 (Reuters) - Burning Rock Biotech Ltd BNR.O :
* BURNING ROCK BIOTECH LIMITED ANNOUNCES EXPECTED DELISTING
OF
AMERICAN DEPOSITARY SHARES
* BURNING ROCK BIOTECH LTD- ANTICIPATED THAT DELISTING WILL
TAKE
EFFECT ON OR ABOUT SEPTEMBER 18, 2024
* BURNING ROCK BIOTECH LTD - FOLLOWING DELISTING, ADSS WILL
CONTINUE TO TRADE ON NASDAQ GLOBAL MARKET
Source text for Eikon: ID:nGNX33W64F
Further company coverage: BNR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Burning Rock Biotech
See all newsBurning Rock Biotech's Q2 revenue falls, net loss widens on central laboratory weakness
China's Burning Rock Biotech Q1 revenue falls on lower test volumes
China's Burning Rock Biotech Q4 net loss narrows as costs fall
Cancer diagnostics firm Burning Rock Biotech's Q3 revenue rises on pharma R&D growth
Brief: Burning Rock's Oncoguide™ Oncoscreen™ Plus CDX System Now Approved In Japan As A Companion Diagnostic For Capivasertib In Breast Cancer